JAZZ PHARMACEUTICALS PLC's ticker is and the CUSIP is G50871905. A total of 3 filers reported holding JAZZ PHARMACEUTICALS PLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,376 | +58.7% | 12,900 | +79.2% | 0.00% | 0.0% |
Q1 2024 | $867 | -40.2% | 7,200 | -39.0% | 0.00% | 0.0% |
Q4 2023 | $1,451 | -33.7% | 11,800 | -30.2% | 0.00% | -50.0% |
Q3 2023 | $2,187 | +69.7% | 16,900 | +62.5% | 0.00% | +100.0% |
Q2 2023 | $1,289 | -12.7% | 10,400 | +3.0% | 0.00% | 0.0% |
Q1 2023 | $1,477 | +231.2% | 10,100 | +248.3% | 0.00% | – |
Q4 2022 | $446 | -100.0% | 2,900 | -73.6% | 0.00% | -100.0% |
Q3 2022 | $1,466,000 | +129.4% | 11,000 | +168.3% | 0.00% | +100.0% |
Q2 2022 | $639,000 | -19.4% | 4,100 | -19.6% | 0.00% | 0.0% |
Q1 2022 | $793,000 | -17.0% | 5,100 | -32.0% | 0.00% | 0.0% |
Q4 2021 | $955,000 | -76.5% | 7,500 | -66.5% | 0.00% | -75.0% |
Q3 2021 | $4,057,000 | +0.6% | 22,400 | -1.3% | 0.00% | 0.0% |
Q2 2021 | $4,032,000 | -6.4% | 22,700 | +8564.1% | 0.00% | -50.0% |
Q1 2021 | $4,306,000 | +243.4% | 262 | +244.7% | 0.01% | +300.0% |
Q4 2020 | $1,254,000 | -42.9% | 76 | -50.6% | 0.00% | -33.3% |
Q3 2020 | $2,195,000 | +503.0% | 154 | +366.7% | 0.00% | +200.0% |
Q2 2020 | $364,000 | -74.5% | 33 | -76.9% | 0.00% | -66.7% |
Q1 2020 | $1,426,000 | -54.3% | 143 | -31.6% | 0.00% | -57.1% |
Q4 2019 | $3,119,000 | +62.3% | 209 | +39.3% | 0.01% | +40.0% |
Q3 2019 | $1,922,000 | -1.6% | 150 | +9.5% | 0.01% | 0.0% |
Q2 2019 | $1,953,000 | -43.1% | 137 | -42.9% | 0.01% | -50.0% |
Q1 2019 | $3,430,000 | +250.4% | 240 | +203.8% | 0.01% | +233.3% |
Q4 2018 | $979,000 | +19.0% | 79 | +61.2% | 0.00% | 0.0% |
Q3 2018 | $823,000 | -48.1% | 49 | -46.7% | 0.00% | -50.0% |
Q2 2018 | $1,585,000 | +11221.4% | 92 | +217.2% | 0.01% | +500.0% |
Q1 2018 | $14,000 | +600.0% | 29 | +81.2% | 0.00% | – |
Q4 2017 | $2,000 | -77.8% | 16 | -71.4% | 0.00% | – |
Q3 2017 | $9,000 | -89.3% | 56 | -52.1% | 0.00% | -100.0% |
Q2 2017 | $84,000 | +200.0% | 117 | +148.9% | 0.00% | +300.0% |
Q1 2017 | $28,000 | +154.5% | 47 | -51.0% | 0.00% | 0.0% |
Q4 2016 | $11,000 | +120.0% | 96 | -6.8% | 0.00% | – |
Q3 2016 | $5,000 | -96.8% | 103 | -60.2% | 0.00% | -100.0% |
Q2 2016 | $156,000 | +387.5% | 259 | +379.6% | 0.01% | +233.3% |
Q1 2016 | $32,000 | -42.9% | 54 | +12.5% | 0.00% | -25.0% |
Q4 2015 | $56,000 | +9.8% | 48 | -15.8% | 0.00% | 0.0% |
Q3 2015 | $51,000 | -61.7% | 57 | -51.3% | 0.00% | -63.6% |
Q2 2015 | $133,000 | -5.7% | 117 | -19.9% | 0.01% | -31.2% |
Q1 2015 | $141,000 | – | 146 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 21,800 | $3,838,000 | 0.05% |
Citadel Advisors | 77,100 | $13,575,000 | 0.01% |
SIMPLEX TRADING, LLC | 117 | $133,000 | 0.01% |